Research News and Research

RSS

New VA Secretary orders independent audit of scheduling practices

Robert McDonald promised to fix problems at the Department of Veterans Affairs that kept veterans from getting care.

12 Aug 2014

Turn-key intervention program increases physical activity levels among kids in daycare

Research led by Dr. Melinda Sothern, Professor and Director of Behavioral & Community Health at the LSU Health Sciences Center New Orleans School of Public Health, reports that a turn-key intervention program significantly increased physical activity levels among children in daycare.

12 Aug 2014

Research: New ways to help visually impaired better navigate everyday life

Visual impairment comes in many forms, and it's on the rise in America. A University of Cincinnati experiment aimed at this diverse and growing population could spark development of advanced tools to help all the aging baby boomers, injured veterans, diabetics and white-cane-wielding pedestrians navigate the blurred edges of everyday life.

12 Aug 2014

Researchers discover highly virulent, multidrug resistant form of pathogen in Ohio

A team of clinician researchers has discovered a highly virulent, multidrug resistant form of the pathogen, Pseudomonas aeruginosa, in patient samples in Ohio.

12 Aug 2014

New mechanism of joint destruction grinds away healthy cartilage, worsens osteoarthritis

A new mechanism of joint destruction caused by a natural material that grinds away healthy cartilage and worsens osteoarthritis has been identified in human hip joints for the first time by University of Liverpool scientists.

12 Aug 2014

Research sheds light on role of hepatic mTORC1 in whole body physiology

The protein mTOR is a central controller of growth and metabolism. Deregulation of mTOR signaling increases the risk of developing metabolic diseases such as diabetes, obesity and cancer.

12 Aug 2014

Mindray net revenues increase 8.9% to $334.5 million in Q2 2014

Mindray Medical International Limited, a leading developer, manufacturer and marketer of medical devices worldwide, announced today its selected unaudited financial results for the second quarter ended June 30, 2014.

From Mindray 12 Aug 2014

GenoSpace completes financing deal with Thomson Reuters

GenoSpace, a precision medicine software company that has developed a comprehensive suite of tools to enable the broad use of genomic data in research and clinical care, today announced that it completed a financing deal with Thomson Reuters, the world leader in providing intelligent information for businesses and professionals.

12 Aug 2014

Out-of-state clinic key to Texas abortion law battle

Challengers of a tough Texas law regulating abortion clinics argue that it would soon close El Paso's sole abortion clinic.

12 Aug 2014

Injecting vaccine-like compound into mice effective in protecting from malaria

A study led by Johns Hopkins Bloomberg School of Public Health researchers found that injecting a vaccine-like compound into mice was effective in protecting them from malaria.

12 Aug 2014

New approach to knocking out parasite's genes

Plasmodium falciparum, the parasite that causes malaria, has proven notoriously resistant to scientists' efforts to study its genetics.

12 Aug 2014

Halozyme reports revenues of $18.4 million, net loss of $16.3 million for Q2 2014

Halozyme Therapeutics, Inc. today reported financial results for the second quarter ended June 30, 2014. Financial highlights for the second quarter include revenues of $18.4 million and a net loss of $16.3 million, or $0.13 per share.

12 Aug 2014

HRIC selects Softheon MC2 to integrate plan offerings for individuals and SHOP plans to FFM

Softheon, Inc., a proven leader in health insurance marketplace integration and business operation, announced today that Health Republic Insurance Company has chosen the Marketplace Connector Cloud (MC2) as their software platform that will integrate and transition its comprehensive plan offerings for individuals and SHOP plans, both on and off Exchange, to the Federally Facilitated Marketplace.

12 Aug 2014

Oncothyreon acquires Alpine Biosciences to enable targeted delivery of multiple therapeutic agents

Oncothyreon Inc., a biotechnology company specializing in the development of innovative therapeutic products for the treatment of cancer, today announced that it has acquired Alpine Biosciences, Inc., of Seattle, Washington, a privately held biotechnology company developing protocells, a nanoparticle platform technology designed to enable the targeted delivery of multiple therapeutic agents, including nucleic acids, proteins, peptides and small molecules.

12 Aug 2014

BioSpecifics Technologies total revenue for second quarter decreases by 19%

BioSpecifics Technologies Corp., a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX® (collagenase clostridium histolyticum or CCH) in the U.S. and XIAPEX® in the EU, today announced its financial results for the second quarter ended June 30, 2014 and provided a corporate update.

12 Aug 2014

Novogen receives funding support to commence studies in muscular dystrophy

The Australian biotechnology company, Novogen Limited today announced receipt of funding from the FSHD Global Research Foundation as part of the Company’s efforts to find effective treatments for a range of musculo-degenerative diseases including facioscapulohumeral dystrophy (FSHD).

11 Aug 2014

Australia introducing breakthrough cerebral palsy treatment

"If Id had a stroke, I wouldn't be happy waiting two years for a diagnosis and treatment, by which time the damage would have become permanent" says Professor Nadia Badawi, Macquarie Group Foundation Chair of cerebral palsy and Head of Research with Cerebral Palsy Alliance "Well that's what we accept with children with cerebral palsy when early intervention in infancy could re-shape their brains, for example using what's called a motor learning approach, where we train the brain to learn new movements."

11 Aug 2014

Research News and Research

New VA Secretary orders independent audit of scheduling practices

Turn-key intervention program increases physical activity levels among kids in daycare

Research: New ways to help visually impaired better navigate everyday life

Researchers discover highly virulent, multidrug resistant form of pathogen in Ohio

New mechanism of joint destruction grinds away healthy cartilage, worsens osteoarthritis

Research sheds light on role of hepatic mTORC1 in whole body physiology

Mindray net revenues increase 8.9% to $334.5 million in Q2 2014

GenoSpace completes financing deal with Thomson Reuters

Out-of-state clinic key to Texas abortion law battle

Injecting vaccine-like compound into mice effective in protecting from malaria

New approach to knocking out parasite's genes

Halozyme reports revenues of $18.4 million, net loss of $16.3 million for Q2 2014

HRIC selects Softheon MC2 to integrate plan offerings for individuals and SHOP plans to FFM

Oncothyreon acquires Alpine Biosciences to enable targeted delivery of multiple therapeutic agents

BioSpecifics Technologies total revenue for second quarter decreases by 19%

Novogen receives funding support to commence studies in muscular dystrophy

Australia introducing breakthrough cerebral palsy treatment

Schizophrenia-linked genetic variations and the developing brain: an interview with Prof. Guo-li Ming

Mucosal lymphoid cells key to S. pneumoniae defence

Researchers discover how immunosensory system attacks viruses on a molecular level

Human iPSCs: A Full Guide to Advanced in Vitro Models and Applications eBook

Latest eBooks

Editorial Focus eBook - Proteomics (2nd Edition)

Industry Focus eBook - Life Science Microscopy (2nd Edition)

BFEB: Advances in microplate-based assays and analysis

Biologics stability screening toolkit: Three practical workflows for accelerating formulation development

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy